Locally Advanced Pancreatic Cancer Global Market Report 2025

Locally Advanced Pancreatic Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on locally advanced pancreatic cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for locally advanced pancreatic cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The locally advanced pancreatic cancer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Therapy: Chemotherapy; Immunotherapy; Radiation Therapy; Surgery

2) By Route Of Administration: Oral; Injectables; Other Route Of Administrations

3) By End-User: Hospital; Specialty Clinics; Research Institutions; Other End-Users

Subsegments:

1) By Chemotherapy: Gemcitabine-based Chemotherapy; FOLFIRINOX Chemotherapy

2) By Immunotherapy: Immune Checkpoint Inhibitors; Cancer Vaccines

3) By Radiation Therapy: External Beam Radiation Therapy; Stereotactic Body Radiation Therapy (SBRT)

4) By Surgery: Pancreaticoduodenectomy (Whipple Procedure); Distal Pancreatectomy; Total Pancreatectomy

Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck KGaA; AbbVie Inc.; Bayer Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Locally Advanced Pancreatic Cancer Market Characteristics
3. Locally Advanced Pancreatic Cancer Market Trends And Strategies
4. Locally Advanced Pancreatic Cancer Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Locally Advanced Pancreatic Cancer Growth Analysis And Strategic Analysis Framework
5.1. Global Locally Advanced Pancreatic Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Locally Advanced Pancreatic Cancer Market Growth Rate Analysis
5.4. Global Locally Advanced Pancreatic Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Locally Advanced Pancreatic Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Locally Advanced Pancreatic Cancer Total Addressable Market (TAM)
6. Locally Advanced Pancreatic Cancer Market Segmentation
6.1. Global Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chemotherapy
Immunotherapy
Radiation Therapy
Surgery
6.2. Global Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectables
Other Route Of Administrations
6.3. Global Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital
Specialty Clinics
Research Institutions
Other End-Users
6.4. Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gemcitabine-based Chemotherapy
FOLFIRINOX Chemotherapy
6.5. Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immune Checkpoint Inhibitors
Cancer Vaccines
6.6. Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
External Beam Radiation Therapy
Stereotactic Body Radiation Therapy (SBRT)
6.7. Global Locally Advanced Pancreatic Cancer Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pancreaticoduodenectomy (Whipple Procedure)
Distal Pancreatectomy
Total Pancreatectomy
7. Locally Advanced Pancreatic Cancer Market Regional And Country Analysis
7.1. Global Locally Advanced Pancreatic Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Locally Advanced Pancreatic Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Locally Advanced Pancreatic Cancer Market
8.1. Asia-Pacific Locally Advanced Pancreatic Cancer Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Locally Advanced Pancreatic Cancer Market
9.1. China Locally Advanced Pancreatic Cancer Market Overview
9.2. China Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Locally Advanced Pancreatic Cancer Market
10.1. India Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Locally Advanced Pancreatic Cancer Market
11.1. Japan Locally Advanced Pancreatic Cancer Market Overview
11.2. Japan Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Locally Advanced Pancreatic Cancer Market
12.1. Australia Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Locally Advanced Pancreatic Cancer Market
13.1. Indonesia Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Locally Advanced Pancreatic Cancer Market
14.1. South Korea Locally Advanced Pancreatic Cancer Market Overview
14.2. South Korea Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Locally Advanced Pancreatic Cancer Market
15.1. Western Europe Locally Advanced Pancreatic Cancer Market Overview
15.2. Western Europe Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Locally Advanced Pancreatic Cancer Market
16.1. UK Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Locally Advanced Pancreatic Cancer Market
17.1. Germany Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Locally Advanced Pancreatic Cancer Market
18.1. France Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Locally Advanced Pancreatic Cancer Market
19.1. Italy Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Locally Advanced Pancreatic Cancer Market
20.1. Spain Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Locally Advanced Pancreatic Cancer Market
21.1. Eastern Europe Locally Advanced Pancreatic Cancer Market Overview
21.2. Eastern Europe Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Locally Advanced Pancreatic Cancer Market
22.1. Russia Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Locally Advanced Pancreatic Cancer Market
23.1. North America Locally Advanced Pancreatic Cancer Market Overview
23.2. North America Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Locally Advanced Pancreatic Cancer Market
24.1. USA Locally Advanced Pancreatic Cancer Market Overview
24.2. USA Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Locally Advanced Pancreatic Cancer Market
25.1. Canada Locally Advanced Pancreatic Cancer Market Overview
25.2. Canada Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Locally Advanced Pancreatic Cancer Market
26.1. South America Locally Advanced Pancreatic Cancer Market Overview
26.2. South America Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Locally Advanced Pancreatic Cancer Market
27.1. Brazil Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Locally Advanced Pancreatic Cancer Market
28.1. Middle East Locally Advanced Pancreatic Cancer Market Overview
28.2. Middle East Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Locally Advanced Pancreatic Cancer Market
29.1. Africa Locally Advanced Pancreatic Cancer Market Overview
29.2. Africa Locally Advanced Pancreatic Cancer Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Locally Advanced Pancreatic Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Locally Advanced Pancreatic Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Locally Advanced Pancreatic Cancer Market Competitive Landscape And Company Profiles
30.1. Locally Advanced Pancreatic Cancer Market Competitive Landscape
30.2. Locally Advanced Pancreatic Cancer Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bayer Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Locally Advanced Pancreatic Cancer Market Other Major And Innovative Companies
31.1. Bristol-Myers Squibb Company
31.2. AstraZeneca plc
31.3. Abbott Laboratories
31.4. Novartis AG
31.5. GSK plc
31.6. Ipsen Biopharmaceuticals Inc.
31.7. Lupin Limited
31.8. NovoCure Limited
31.9. Theratechnologies Inc.
31.10. XBiotech
31.11. Prestige Biopharma
31.12. OSE Immunotherapeutics
31.13. Helix Biopharma Corporation
31.14. Fawn Incorporation
31.15. Eli Lilly and Co
32. Global Locally Advanced Pancreatic Cancer Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Locally Advanced Pancreatic Cancer Market
34. Recent Developments In The Locally Advanced Pancreatic Cancer Market
35. Locally Advanced Pancreatic Cancer Market High Potential Countries, Segments and Strategies
35.1 Locally Advanced Pancreatic Cancer Market In 2029 - Countries Offering Most New Opportunities
35.2 Locally Advanced Pancreatic Cancer Market In 2029 - Segments Offering Most New Opportunities
35.3 Locally Advanced Pancreatic Cancer Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings